Avricore Historical Cash Flow
| AVCR Stock | CAD 0.05 0.01 11.11% |
Analysis of Avricore Health cash flow over time is an excellent tool to project Avricore Health future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 342.8 K or Capital Expenditures of 1.3 M as it is a great indicator of Avricore Health ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Avricore Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Avricore Health is a good buy for the upcoming year.
Avricore |
About Avricore Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Avricore balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Avricore's non-liquid assets can be easily converted into cash.
Avricore Health Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Avricore Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Avricore Health current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avricore Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Avricore Health's Change In Working Capital is fairly stable compared to the past year. Other Cashflows From Financing Activities is likely to climb to about 342.8 K in 2025, whereas Free Cash Flow is likely to drop (365.2 K) in 2025.
| 2022 | 2023 | 2024 | 2025 (projected) | Begin Period Cash Flow | 2.0M | 620.5K | 713.6K | 537.1K | End Period Cash Flow | 620.5K | 276.6K | 318.1K | 623.9K |
Avricore Health cash flow statement Correlations
Click cells to compare fundamentals
Avricore Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Avricore Health cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 288.9K | 1.7M | (1.4M) | (344.0K) | (309.6K) | (294.1K) | |
| Free Cash Flow | (1.2M) | (1.4M) | (1.6M) | (386.5K) | (347.8K) | (365.2K) | |
| Change In Working Capital | (470.7K) | (78.2K) | (142.8K) | 233.3K | 210.0K | 220.5K | |
| Other Cashflows From Financing Activities | 30.7K | 900.0K | 1.7M | 253.9K | 292.0K | 342.8K | |
| Total Cash From Operating Activities | (1.2M) | (1.2M) | (437.8K) | 660.4K | 594.4K | 624.1K | |
| Net Income | (1.2M) | (1.7M) | (818.2K) | (701.2K) | (631.1K) | (662.6K) | |
| Total Cash From Financing Activities | 1.5M | 3.1M | 253.9K | 42.5K | 48.9K | 46.4K | |
| End Period Cash Flow | 302.7K | 2.0M | 620.5K | 276.6K | 318.1K | 623.9K | |
| Begin Period Cash Flow | 13.8K | 302.7K | 2.0M | 620.5K | 713.6K | 537.1K | |
| Depreciation | 14.5K | 18.0K | 183.0K | 420.1K | 483.1K | 507.2K | |
| Other Non Cash Items | 291.0K | 38.4K | 8.7K | (1.0) | (0.9) | (0.85) | |
| Stock Based Compensation | 130.2K | 495.8K | 331.5K | 703.6K | 809.2K | 445.5K | |
| Change To Operating Activities | 161.3K | 107.1K | 45.3K | 71.0K | 81.6K | 85.7K | |
| Change To Netincome | 1.8M | 761.0K | 421.2K | 534.2K | 480.8K | 857.9K | |
| Change To Liabilities | (53.6K) | 364.3K | (339.0K) | (69.6K) | (62.6K) | (59.5K) | |
| Investments | (4.3K) | (140.4K) | (1.2M) | (1.0M) | (942.2K) | (895.1K) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avricore Stock Analysis
When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.